Zenas Biopharma, Inc. Investors: Please Contact The Portnoy Law Firm To Recover Your Losses June 16, 2025 Deadline To File Lead Plaintiff Motion. Date. 2025-06-10 06:45:42.

Zenas Biopharma, Inc. Investors: Please Contact The Portnoy Law Firm To Recover Your Losses June 16, 2025 Deadline To File Lead Plaintiff Motion. Date. 2025-06-04 05:00:54.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Zenas BioPharma, Inc. ("Zenas BioPharma, Inc." or the "Company") (NASDAQ: ZBIO) of a class action securities ...

WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a ...

The Zenas BioPharma class action lawsuit further alleges that on November 12, 2024, Zenas BioPharma filed its quarterly report for the period ended September 30, 2024, ...

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: Zenas BioPharma is a clinical ...

Zenas BioPharma reports ongoing Phase 2 and Phase 3 trials, leadership appointments, and financial results for Q1 2025. Quiver AI Summary. Zenas BioPharma, Inc. provided an update on its clinical ...

Insiders who bought US$2.11m worth of Zenas BioPharma, Inc. (NASDAQ:ZBIO) stock in the last year have seen some of their losses recouped as the stock gained 12% last week. However, the purchase is ...

WALTHAM, Mass. - Zenas BioPharma, Inc. (NASDAQ:ZBIO), a clinical-stage biopharmaceutical company with a market capitalization of $322 million, today announced the appointment of Haley Laken, Ph.D ...

We will compare Zenas Biopharma to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, earnings, valuation and risk ...

Analysts expect Zenas Biopharma to post earnings of ($0.92) per share for the quarter. Zenas Biopharma Stock Down 2.2 % ZBIO opened at $8.33 on Monday. The firm has a market […] ...